Novel Cardiovascular Risk Factor Prediction of Cardiovascular Events in the (Type 2 Diabetes) FIELD Study and Effects of Fenofibrate

被引：0
|
作者：
Keech, Anthony C.
Alicia, Jenkins
Whiting, Malcolm
Barter, Philip
Sullivan, David R.
Donoghoe, Mark
Januszewski, Andrej
Karschimkus, Connie
Blankenberg, Stefan
Simes, John
Scott, Russell
Laakso, Markku
Taskinen, Marja-Riitta
Best, James D.
机构：
[1] Univ Sydney, Sydney, NSW 2006, Australia
[2] Univ Melbourne, Melbourne, Vic, Australia
[3] Flinders Univ S Australia, Adelaide, SA 5001, Australia
[4] Royal Prince Alfred Hosp, Sydney, NSW, Australia
[5] Johannes Gutenberg Univ Mainz, Mainz, Germany
[6] Christchurch Hosp, Christchurch, New Zealand
[7] Univ Kuopio, FIN-70211 Kuopio, Finland
[8] Helsinki Univ Hosp, Helsinki, Finland
来源：
CIRCULATION | 2010年 / 122卷 / 21期
关键词：
Biomarkers; Risk factors; Cardiovascular disease; Type; 2; Diabetes;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A18865
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Hyperglycemia as a risk factor for cardiovascular disease in type 2 diabetes
    Laakso, M
    PRIMARY CARE, 1999, 26 (04): : 829 - +
  • [32] Risk of cardiovascular events associated with pathophysiological phenotypes of type 2 diabetes
    Stidsen, Jacob Volmer
    Christensen, Diana Hedevang
    Henriksen, Jan Erik
    Hojlund, Kurt
    Olsen, Michael Hecht
    Thomsen, Reimar Wernick
    Christensen, Lotte Brix
    Nielsen, Jens Steen
    Olesen, Thomas Bastholm
    Beck-Nielsen, Henning
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2022, 187 (02) : 279 - 291
  • [33] Peripheral neuropathy and the risk of cardiovascular events in type 2 diabetes mellitus
    Brownrigg, Jack R. W.
    de Lusignan, Simon
    McGovern, Andrew
    Hughes, Cian
    Thompson, Matthew M.
    Ray, Kausik K.
    Hinchliffe, Robert J.
    HEART, 2014, 100 (23) : 1837 - +
  • [34] Risk for cardiovascular events in an Italian population of patients with type 2 diabetes
    Pellegrini, E.
    Maurantonio, M.
    Giannico, I. M.
    Simonini, M. S.
    Ganazzi, D.
    Carulli, L.
    D'Amico, R.
    Baldini, A.
    Loria, P.
    Bertolotti, M.
    Carulli, N.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2011, 21 (11) : 885 - 892
  • [35] Cardiovascular risk prediction in adults with type 1 diabetes: The Fremantle Diabetes Study
    Davis, Wendy A.
    Davis, Timothy M. E.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 90 (03) : E75 - E78
  • [36] Fenofibrate and cardiovascular risk: a synopsis and commentary on (FIELD)
    Bailey, CJ
    DIABETIC MEDICINE, 2006, 23 (02) : 109 - 112
  • [37] EFFECTS OF OBESITY AND TYPE 2 DIABETES ON THE 30 YEAR RISK OF CARDIOVASCULAR EVENTS IN YOUNG ADULTS
    Khoury, P. R.
    Daniels, S. R.
    Kimball, T. R.
    Urbina, E. M.
    Dolan, L. H.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2011, 173 : S307 - S307
  • [38] Cardiovascular risk in type 2 diabetes
    Standl, E
    DIABETES OBESITY & METABOLISM, 1999, 1 : S24 - S36
  • [39] Type 2 diabetes and cardiovascular risk
    Robinson, Jennifer G.
    Schmeltz, Lowell R.
    Stone, Neil J.
    MEDICAL CLINICS OF NORTH AMERICA, 2008, 92 : 37 - 48
  • [40] Effects Of Aerobic And Resistance Training On Novel Cardiovascular Risk Factors In Type 2 Diabetes
    Kadoglou, Nikolaos P. E.
    Vrabas, Ioannis S.
    Angelopoulou-Sakadami, Nikoleta
    Sailer, Nikolaos
    Athanasiadou, Zeta
    Vitta, Ioulia
    Liapis, Christos D.
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2008, 40 (05): : S73 - S73
12345